MedPath

Hippocampal blood flow and electroconvulsive therapy in depressio

Completed
Conditions
Depression
Depressive disorder
10027946
Registration Number
NL-OMON29749
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

Patients who meet DSM-IV criteria for depressive disorder and meet the Dutch Psychiatric Association criteria for electroconvulsive therapy. Healthy control subjects who do not meet any DSM-IV criteria. Age between 18 and 65.

Exclusion Criteria

Patients who do not meet DSM-IV criteria for depressive disorder. Healthy controls who meet the criteria for a DSM-IV diagnosis. Subjects who have severe cognitive impairments (e.g. vascular or Alzheimers dementia), severe medical conditions (e.g. coronaire heart disease, COPD, diabetes), non removable metal objects. Subjects who are pregnant or lactating.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary study parameter will be changes in hippocampal blood flow as a<br /><br>result of ECT measured in ml/min/100g</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Differences in hippocampal bloodflow between depressed patients and healthy<br /><br>controls measured in ml/min/100mg.<br /><br>Changes in depression score before and after ECT treatment as measured by means<br /><br>of the Hamilton depression rating scale.</p><br>
© Copyright 2025. All Rights Reserved by MedPath